The nation of Zimbabwe has turned down a major US health deal valued at 367 million US dollars (£272m) spanning five years over Washington's insistence on confidential data.
The decision became public following a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "unbalanced".
An official spokesman has since clarified that the US was requesting genetic material for scientific study and commercial gain while refused to guarantee the resulting advantages from future vaccines.
"We will now turn to the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged further negotiations to find a agreement agreeable to both sides so the country's critical HIV treatment initiative can continue.
Wider Background
This rejection follows a comparable case in Kenya, where a court suspended a similar health funding agreement following legal challenges were raised about the safety of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government deals to boost transparency and accountability.
As per statements, Sixteen nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, with no equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Effectively, our country would provide the basic resources for medical research with no assurance that the end products would be available to our people should a new disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its pursuit of one-on-one health agreements were upending structures previously set up via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage potential global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We are open to ongoing discussions with our US partners on how subsequent collaboration might be structured in a way that honours the independence and dignity of both nations."
Medical Community Response
A leading public health body stated it understood the government's concerns, but suggested that talks must proceed since much of the country's HIV programmes were funded by international support.
"Where technical issues arise, including those relating to information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," it commented.
The situation emphasises the ongoing debate between accepting crucial foreign assistance and safeguarding national sovereignty in an ever more data-driven world.